Assignee
TOOLGEN INC
KR19 patents
Top patents by PatentIndex Score
US10851380B2Dec 1, 2020
Methods for cleaving a target DNA using a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein
TOOLGEN INC47 citations97
US7514257B2Apr 7, 2009
Zinc finger transcription factor differentiation proteins
TOOLGEN INC32 citations92
US10519454B2Dec 31, 2019
Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGEN
TOOLGEN INC15 citations85
US12473559B2Nov 18, 2025
Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cells
TOOLGEN INC0 citations61
US12509697B2Dec 30, 2025
Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof
TOOLGEN INC0 citations59
US12331086B2Jun 17, 2025
Artificially engineered SC function control system
TOOLGEN INC0 citations59
US12286635B2Apr 29, 2025
Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof
TOOLGEN INC0 citations59
US12163149B2Dec 10, 2024
Artificial genome manipulation for gene expression regulation
TOOLGEN INC0 citations56
US11572574B2Feb 7, 2023
Artificial genome manipulation for gene expression regulation
TOOLGEN INC0 citations56
US12486521B2Dec 2, 2025
Platform for expressing protein of interest in liver
TOOLGEN INC0 citations55
US11667934B2Jun 6, 2023
Platform for expressing protein of interest in liver
TOOLGEN INC0 citations55
US11441135B2Sep 13, 2022
Target-specific CRISPR mutant
TOOLGEN INC1 citations55
US12275963B2Apr 15, 2025
Artificially manipulated immune cell
TOOLGEN INC0 citations50
US12012598B2Jun 18, 2024
Manipulated immunoregulatory element and immunity altered thereby
TOOLGEN INC0 citations50
US11999952B2Jun 4, 2024
Artificially-manipulated neovascularization regulatory system
TOOLGEN INC0 citations50
US11920151B2Mar 5, 2024
Method for identifying DNA base editing by means of cytosine deaminase
TOOLGEN INC0 citations48
US11845951B2Dec 19, 2023
Gene manipulation for treatment of retinal dysfunction disorder
TOOLGEN INC0 citations48
US12351838B2Jul 8, 2025
Target-specific CRISPR mutant
TOOLGEN INC0 citations44
US12241071B2Mar 4, 2025
Composition for editing flavonoid biosynthetic gene by using CRISPR/Cas9 system, and use thereof
TOOLGEN INC0 citations31